Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 21 -26 of 26 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


21.		Phase I Study of Oral N-Methylformamide (NSC-3051)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				no age specified				NCI				RWGH-8342253 NCI-T83-1056W

Last Modified: 12/18/2007


22.		Phase I Study of N-Methylformamide (N-MF) (NSC-3051) in Patients with Advanced Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				20 to 75								NCI-W82-0925 W82-0925


23.		Phase I Study of N-Methylformamide

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				no age specified								NCI-W82-1366 UMCC-8227

Last Modified: 7/17/2007


24.		Phase I Study of Oral N-MF in Patients with Advanced Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				18 to 75				NCI				JHOC-85091603 NCI-T85-0238W, T85-0238

Last Modified: 5/1/1988


25.		Phase I Radiosensitization with N-MF plus Radiotherapy in Patients with Advanced Cancer Refractory or Poorly Responsive to Conventional Therapy (Summary Last Modified 05/88)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				16 and over				NCI				RIH-871 NCI-T86-0300O, T86-0300


26.		Phase I Study of N-Methylformamide (N-MF, NSC-3051)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				no age specified								NCI-W82-0697 RWGH-8441153

Select All on One Page


					< Previous 1 2 3

| | | | | | | |

A Service of the National Cancer Institute